Literature DB >> 11270727

Monoamine oxidase inhibitors from rhizoma of Coptis chinensis.

L D Kong, C H Cheng, R X Tan.   

Abstract

Three protoberberine alkaloids jatrorrhizine, berberine and palmatine were isolated from the monoamine oxidase (MAO) inhibitory fraction of the methanol extract of Coptis chinensis rhizoma. Jatrorrhizine was shown to inhibit non-competitively both MAO-A and -B from rat brain mitochondria with the IC50 values of 4 and 62 microM, respectively. Berberine only competitively inhibited MAO-A with an IC50 values of 126 microM whereas palmatine exhibited, up to 200 microM, no inhibition on any type of the enzyme. The structure-activity relationship was briefly discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11270727     DOI: 10.1055/s-2001-10874

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  19 in total

1.  Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine.

Authors:  Yanwei Duan; Tian Liu; Yong Zhou; Tongyi Dou; Qing Yang
Journal:  J Biol Chem       Date:  2018-08-22       Impact factor: 5.157

Review 2.  Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.

Authors:  Tapan Behl; Sukhbir Singh; Neelam Sharma; Ishrat Zahoor; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

Review 3.  Selective MAO-B inhibitors: a lesson from natural products.

Authors:  Simone Carradori; Melissa D'Ascenzio; Paola Chimenti; Daniela Secci; Adriana Bolasco
Journal:  Mol Divers       Date:  2013-11-12       Impact factor: 2.943

Review 4.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

5.  Berberine ameliorates cold and mechanical allodynia in a rat model of diabetic neuropathy.

Authors:  Si Oh Kim; Hyun Jee Kim
Journal:  J Med Food       Date:  2013-06-04       Impact factor: 2.786

Review 6.  Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases.

Authors:  Esra Küpeli Akkol; Irem Tatlı Çankaya; Gökçe Şeker Karatoprak; Elif Carpar; Eduardo Sobarzo-Sánchez; Raffaele Capasso
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

7.  Molecular basis of inhibitory activities of berberine against pathogenic enzymes in Alzheimer's disease.

Authors:  Hong-Fang Ji; Liang Shen
Journal:  ScientificWorldJournal       Date:  2012-01-04

Review 8.  Potential benefits of berberine in the management of perimenopausal syndrome.

Authors:  Cristiana Caliceti; Paola Rizzo; Arrigo Francesco Giuseppe Cicero
Journal:  Oxid Med Cell Longev       Date:  2015-02-17       Impact factor: 6.543

9.  Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS.

Authors:  Cheng-Fu Chang; Yi-Chao Lee; Kuen-Haur Lee; Hui-Ching Lin; Chia-Ling Chen; Che-Kun James Shen; Chi-Chen Huang
Journal:  J Biomed Sci       Date:  2016-10-21       Impact factor: 8.410

10.  A Peroxidase-linked Spectrophotometric Assay for the Detection of Monoamine Oxidase Inhibitors.

Authors:  Kangkang Zhi; Zhongduo Yang; Jie Sheng; Zongmei Shu; Yin Shi
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.